Met Life Investment Management, LLC Chinook Therapeutics, Inc. Transaction History

Met Life Investment Management, LLC

$17.1 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Apr 29, 2024	BUY	$18.66 - $38.58 $570,716 - $1.18 Million	30,585 New	30,585 $1.18 Million
Q2 2023 Aug 10, 2023	BUY	$18.66 - $38.58 $76,319 - $157,792	4,090 Added 15.44%	30,585 $1.18 Million
Q1 2023 May 09, 2024	BUY	$21.53 - $26.8 $570,437 - $710,066	26,495 New	26,495 $613 Million
Q3 2022 May 10, 2024	BUY	$17.51 - $23.37 $76,886 - $102,617	4,391 Added 19.87%	26,495 $520,000
Q3 2022 Mar 22, 2023	BUY	$17.51 - $23.37 $76,886 - $102,617	4,391 Added 19.87%	26,495 $520,000
Q3 2022 Nov 14, 2022	BUY	$17.51 - $23.37 $76,886 - $102,617	4,391 Added 19.87%	26,495 $521,000
Q2 2022 May 10, 2024	BUY	$12.59 - $18.8 $28,516 - $42,582	2,265 Added 11.42%	22,104 $386,000
Q2 2022 Jun 20, 2023	SELL	$12.59 - $18.8 $55,282 - $82,550	-4,391 Reduced 16.57%	22,104 $386,000
Q2 2022 Mar 22, 2023	BUY	$12.59 - $18.8 $28,516 - $42,582	2,265 Added 11.42%	22,104 $386,000
Q2 2022 Aug 11, 2022	BUY	$12.59 - $18.8 $28,516 - $42,582	2,265 Added 11.42%	22,104 $387,000
Q1 2022 May 10, 2024	BUY	$12.02 - $16.69 $238,464 - $331,112	19,839 New	19,839 $324,000
Q1 2022 Jun 20, 2023	SELL	$12.02 - $16.69 $80,005 - $111,088	-6,656 Reduced 25.12%	19,839 $324,000
Q1 2022 Mar 22, 2023	BUY	$12.02 - $16.69 $88,010 - $122,204	7,322 Added 58.5%	19,839 $324,000
Q1 2022 May 12, 2022	BUY	$12.02 - $16.69 $88,010 - $122,204	7,322 Added 58.5%	19,839 $325,000
Q4 2021 Jun 21, 2023	SELL	$10.69 - $16.83 $149,424 - $235,249	-13,978 Reduced 52.76%	12,517 $204,000
Q3 2021 Jun 21, 2023	SELL	$11.5 - $14.86 $160,747 - $207,713	-13,978 Reduced 52.76%	12,517 $159,000
Q2 2021 May 17, 2024	BUY	$13.6 - $18.98 $170,231 - $237,572	12,517 New	12,517 $176,000
Q2 2021 Jun 21, 2023	SELL	$13.6 - $18.98 $190,100 - $265,302	-13,978 Reduced 52.76%	12,517 $176,000
Q2 2021 Mar 22, 2023	BUY	$13.6 - $18.98 $82,592 - $115,265	6,073 Added 94.24%	12,517 $176,000
Q2 2021 Aug 16, 2021	BUY	$13.6 - $18.98 $170,231 - $237,572	12,517 New	12,517 $177,000
Q1 2021 May 14, 2021	SELL	$14.17 - $19.11 $91,311 - $123,144	-6,444 Closed	0 $0
Q4 2020 May 24, 2024	BUY	$11.9 - $20.91 $76,683 - $134,744	6,444 New	6,444 $102,000
Q4 2020 Jun 22, 2023	SELL	$11.9 - $20.91 $238,606 - $419,266	-20,051 Reduced 75.68%	6,444 $102,000
Q4 2020 Mar 22, 2023	SELL	$11.9 - $20.91 $238,606 - $419,266	-20,051 Reduced 75.68%	6,444 $102,000
Q4 2020 Feb 16, 2021	BUY	$11.9 - $20.91 $76,683 - $134,744	6,444 New	6,444 $102,000

Others Institutions Holding KDNY

# of Institutions

Shares Held

234K

Call Options Held

Put Options Held

View Full List

About CHINOOK THERAPEUTICS, INC.

Ticker KDNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,896,300
Description
Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's lead clinical program is atrasentan, a Phase III endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. ...

More about KDNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account